| Joseph C Sullivan Iii, MD | |
|
11375 Cortez Blvd, Brooksville, FL 34613-5409 | |
| (904) 236-5884 | |
| (904) 346-4334 |
| Full Name | Joseph C Sullivan Iii |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 26 Years |
| Location | 11375 Cortez Blvd, Brooksville, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043303548 | NPI | - | NPPES |
| 04923068 | Medicaid | MS | |
| 051543136 | Other | AL | BCBS |
| 051543144 | Other | AL | BCBS |
| 009942662 | Medicaid | AL | |
| 009942659 | Medicaid | AL | |
| 199147922A | Medicaid | GA | |
| 009942658 | Medicaid | AL | |
| 009942660 | Medicaid | AL | |
| 051543137 | Other | AL | BCBS |
| 051543142 | Other | AL | BCBS |
| P00406959 | Other | AL | RR MEDICARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sarasota Memorial Hospital | Sarasota, FL | Hospital |
| Steward Sebastian River Medical Center | Sebastian, FL | Hospital |
| Lower Keys Medical Center | Key west, FL | Hospital |
| Sacred Heart Hospital | Pensacola, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mori Bean And Brooks Inc | 8820077878 | 633 |
News Archive
The once disgraced politician says expanding health care accessibility will be a key part of his campaign. He finds fault with part of the health law but is more critical of Gov. Bobby Jindal's decision not to expand Medicaid.
Ampio Pharmaceuticals, Inc. announced today that the FDA has accepted the Company's IND for Optina™ for the treatment of diabetic macular edema (DME). Ampio plans to commence enrollment in a clinical trial in the first quarter of 2013. The FDA granted Optina™ 505(b)(2) status in July, 2012. Drugs designated under this pathway can be approved on a single trial.
Research at the University of Liverpool has explained how cells behave when placed in a low oxygen environment, a development that could have implications for cancer patients and other serious illnesses.
Cerevance, a clinical-stage drug discovery and development company focused on brain diseases, today announced the start of dosing in a Phase I first-in-human clinical trial of CVN424, an oral compound being developed for symptomatic treatment of Parkinson's disease.
The 32ed Annual Scientific Meeting of the American Pain Society will convene May 8-11 at the New Orleans Convention Center.
› Verified 2 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
The once disgraced politician says expanding health care accessibility will be a key part of his campaign. He finds fault with part of the health law but is more critical of Gov. Bobby Jindal's decision not to expand Medicaid.
Ampio Pharmaceuticals, Inc. announced today that the FDA has accepted the Company's IND for Optina™ for the treatment of diabetic macular edema (DME). Ampio plans to commence enrollment in a clinical trial in the first quarter of 2013. The FDA granted Optina™ 505(b)(2) status in July, 2012. Drugs designated under this pathway can be approved on a single trial.
Research at the University of Liverpool has explained how cells behave when placed in a low oxygen environment, a development that could have implications for cancer patients and other serious illnesses.
Cerevance, a clinical-stage drug discovery and development company focused on brain diseases, today announced the start of dosing in a Phase I first-in-human clinical trial of CVN424, an oral compound being developed for symptomatic treatment of Parkinson's disease.
The 32ed Annual Scientific Meeting of the American Pain Society will convene May 8-11 at the New Orleans Convention Center.
› Verified 2 days ago
| Entity Name | Mori Bean And Brooks Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093782070 PECOS PAC ID: 8820077878 Enrollment ID: O20190729002602 |
News Archive
The once disgraced politician says expanding health care accessibility will be a key part of his campaign. He finds fault with part of the health law but is more critical of Gov. Bobby Jindal's decision not to expand Medicaid.
Ampio Pharmaceuticals, Inc. announced today that the FDA has accepted the Company's IND for Optina™ for the treatment of diabetic macular edema (DME). Ampio plans to commence enrollment in a clinical trial in the first quarter of 2013. The FDA granted Optina™ 505(b)(2) status in July, 2012. Drugs designated under this pathway can be approved on a single trial.
Research at the University of Liverpool has explained how cells behave when placed in a low oxygen environment, a development that could have implications for cancer patients and other serious illnesses.
Cerevance, a clinical-stage drug discovery and development company focused on brain diseases, today announced the start of dosing in a Phase I first-in-human clinical trial of CVN424, an oral compound being developed for symptomatic treatment of Parkinson's disease.
The 32ed Annual Scientific Meeting of the American Pain Society will convene May 8-11 at the New Orleans Convention Center.
› Verified 2 days ago
| Entity Name | Tower Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467654244 PECOS PAC ID: 2860470077 Enrollment ID: O20230815000541 |
News Archive
The once disgraced politician says expanding health care accessibility will be a key part of his campaign. He finds fault with part of the health law but is more critical of Gov. Bobby Jindal's decision not to expand Medicaid.
Ampio Pharmaceuticals, Inc. announced today that the FDA has accepted the Company's IND for Optina™ for the treatment of diabetic macular edema (DME). Ampio plans to commence enrollment in a clinical trial in the first quarter of 2013. The FDA granted Optina™ 505(b)(2) status in July, 2012. Drugs designated under this pathway can be approved on a single trial.
Research at the University of Liverpool has explained how cells behave when placed in a low oxygen environment, a development that could have implications for cancer patients and other serious illnesses.
Cerevance, a clinical-stage drug discovery and development company focused on brain diseases, today announced the start of dosing in a Phase I first-in-human clinical trial of CVN424, an oral compound being developed for symptomatic treatment of Parkinson's disease.
The 32ed Annual Scientific Meeting of the American Pain Society will convene May 8-11 at the New Orleans Convention Center.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph C Sullivan Iii, MD Po Box 116700, Atlanta, GA 30368-6700 Ph: (904) 236-5884 | Joseph C Sullivan Iii, MD 11375 Cortez Blvd, Brooksville, FL 34613-5409 Ph: (904) 236-5884 |
News Archive
The once disgraced politician says expanding health care accessibility will be a key part of his campaign. He finds fault with part of the health law but is more critical of Gov. Bobby Jindal's decision not to expand Medicaid.
Ampio Pharmaceuticals, Inc. announced today that the FDA has accepted the Company's IND for Optina™ for the treatment of diabetic macular edema (DME). Ampio plans to commence enrollment in a clinical trial in the first quarter of 2013. The FDA granted Optina™ 505(b)(2) status in July, 2012. Drugs designated under this pathway can be approved on a single trial.
Research at the University of Liverpool has explained how cells behave when placed in a low oxygen environment, a development that could have implications for cancer patients and other serious illnesses.
Cerevance, a clinical-stage drug discovery and development company focused on brain diseases, today announced the start of dosing in a Phase I first-in-human clinical trial of CVN424, an oral compound being developed for symptomatic treatment of Parkinson's disease.
The 32ed Annual Scientific Meeting of the American Pain Society will convene May 8-11 at the New Orleans Convention Center.
› Verified 2 days ago
Harvey N Esrov, MD Radiology Medicare: Medicare Enrolled Practice Location: 11375 Cortez Blvd, Brooksville, FL 34613 Phone: 813-920-5200 Fax: 813-920-5228 | |
Mr. Naveen Bikkasani, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 13470 Taft St, Brooksville, FL 34613 Phone: 352-597-0016 Fax: 352-597-0089 | |
Mr. Venkata Rao Emandi, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 14535 Cortez Blvd, Brooksville, FL 34613 Phone: 352-596-3622 Fax: 352-596-0901 | |
Dr. Raymond J Perez, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 11375 Cortez Blvd, Brooksville, FL 34613 Phone: 813-890-8004 Fax: 727-518-0762 | |
Mr. John Meyer Iii, Radiology Medicare: Accepting Medicare Assignments Practice Location: 11375 Cortez Blvd, Brooksville, FL 34613 Phone: 904-399-5800 | |
Dr. Dalila Nieves-cruz, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 17240 Cortez Blvd, Brooksville, FL 34601 Phone: 352-796-5111 |